Kelly Carroll is a Board Member at OrthoSens and a seasoned life sciences executive with a strong track record in pharma launch excellence, commercial operations, and new market entry. She has led major business transformation programs for Sandoz/Novartis and Astellas Pharma, driving growth and efficiency across global markets. An active adviser, angel investor, and limited partner in the Swiss start-up ecosystem—with investments extending to Canada and the U.S.—Kelly also mentors founders through SPARK Switzerland, bringing deep, hands-on go-to-market and commercialization expertise to emerging HealthTech and MedTech ventures.